Lidco
LiDCO hemodynamic monitoring enables fluid and drug management for critically ill patients.
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 10.0m | 9.0m | 8.0m | 9.0m | - | - | - |
| % growth | - | (10 %) | (11 %) | 13 % | - | - | - |
| EBITDA | 1.0m | (2.0m) | (1.0m) | (1.4m) | (<1m) | 28.4m | 1.2m |
| % EBITDA margin | 10 % | (22 %) | (13 %) | (15 %) | - | - | - |
| Profit | - | <1m | <1m | <1m | - | - | - |
| % profit margin | - | 1 % | 3 % | 2 % | - | - | - |
| R&D budget | 6.0m | 6.0m | 6.0m | 6.0m | - | - | - |
| R&D % of revenue | 60 % | 67 % | 75 % | 67 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
£31.1m | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Lidco
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.